CoChat

Vigorous physical activity, incident heart disease, and cancer: how little is enough?

Open access
Ahmadi, Matthew N, Clare, Philip J, Katzmarzyk, Peter T, del Pozo Cruz, Borja, Lee, I Min, Stamatakis, Emmanuel · 2022 · European Heart Journal

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Abstract

Aims: Vigorous physical activity (VPA) is a time-efficient way to achieve recommended physical activity levels. There is a very limited understanding of the minimal and optimal amounts of vigorous physical activity in relation to mortality and disease incidence. Methods and results: A prospective study in 71 893 adults [median age (IQR): 62.5 years (55.3, 67.7); 55.9% female] from the UK Biobank cohort with wrist-worn accelerometry. VPA volume (min/week) and frequency of short VPA bouts (≤2 min) were measured. The dose–response associations of VPA volume and frequency with mortality [all-cause, cardiovascular disease (CVD) and cancer], and CVD and cancer incidence were examined after excluding events occurring in the first year. During a mean post-landmark point follow-up of 5.9 years (SD ± 0.8), the adjusted 5-year absolute mortality risk was 4.17% (95% confidence interval: 3.19%, 5.13%) for no VPA, 2.12% (1.81%, 2.44%) for >0 to <10 min, 1.78% (1.53%, 2.03%) for 10 to <30 min, 1.47% (1.21%, 1.73%) for 30 to <60 min, and 1.10% (0.84%, 1.36%) for ≥60 min. The ‘optimal dose’ (nadir of the curve) was 53.6 (50.5, 56.7) min/week [hazard ratio (HR): 0.64 (0.54, 0.77)] relative to the 5th percentile reference (2.2 min/week). There was an inverse linear dose-response association of VPA with CVD mortality. The ‘minimal’ volume dose (50% of the optimal dose) was ∼15 (14.3, 16.3) min/week for all-cause [HR: 0.82 (0.75, 0.89)] and cancer [HR: 0.84 (0.74, 0.95)] mortality, and 19.2 (16.5, 21.9) min/week [HR: 0.60 (0.50, 0.72)] for CVD mortality. These associations were consistent for CVD and cancer incidence. There was an inverse linear association between VPA frequency and CVD mortality. 27 (24, 30) bouts/week was associated with the lowest all-cause mortality [HR: 0.73 (0.62, 0.87)]. Conclusion: VPA of 15–20 min/week were associated with a 16–40% lower mortality HR, with further decreases up to 50–57 min/week. These findings suggest reduced health risks may be attainable through relatively modest amounts of VPA accrued in short bouts across the week.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehac572

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Structured Graphical Abstract Approximately 15–20 min of vigorous activity/week accrued through short bouts were associated with lower mortality and disease incidence. VPA = vigorous physical activity.
Structured Graphical Abstract Approximately 15–20 min of vigorous activity/week accrued through short bouts were associated with lower mortality and disease incidence. VPA = vigorous physical activity.CC BY-NC · PubMed Central
Figure 1 Adjusted absolute risk estimates for mortality and disease incidence by vigorous physical activity volume (minutes/week). Adjusted for age, sex, wear time, light intensity, moderate intensity, frequency of vigorous bouts, smoking history, alcohol consumption, sleep score, diet, discretionary screen-time, education, self-reported parental history of CVD and cancer, and self-reported medication use (cholesterol, blood pressure, and diabetes). The range was capped at the 97.5 percentile to minimize the influence of sparse data. Mortality: n = 71 893; events: all-cause = 1,927, cardiovascular disease = 602, cancer = 1150. Cardiovascular disease: n = 71,049, events = 4567. Cancer: n = 71,070, events = 2854.
Figure 1 Adjusted absolute risk estimates for mortality and disease incidence by vigorous physical activity volume (minutes/week). Adjusted for age, sex, wear time, light intensity, moderate intensity, frequency of vigorous bouts, smoking history, alcohol consumption, sleep score, diet, discretionary screen-time, education, self-reported parental history of CVD and cancer, and self-reported medication use (cholesterol, blood pressure, and diabetes). The range was capped at the 97.5 percentile to minimize the influence of sparse data. Mortality: n = 71 893; events: all-cause = 1,927, cardiovascular disease = 602, cancer = 1150. Cardiovascular disease: n = 71,049, events = 4567. Cancer: n = 71,070, events = 2854.CC BY-NC · PubMed Central
Figure 2 Adjusted 5-year risk for mortality and disease incidence by vigorous physical activity volume groups. Timescale was follow-up years. Adjusted for age, sex, wear time, light intensity, moderate intensity, frequency of vigorous bouts, smoking history, alcohol consumption, sleep score, diet, discretionary screen-time, education, self-reported parental history of CVD and cancer, and self-reported medication use (cholesterol, blood pressure, and diabetes). Mortality: n = 71 893; events: all-cause = 1,927, cardiovascular disease = 602, cancer = 1150. Cardiovascular disease: n = 71,049, events = 4567. Cancer: n = 71,070, events = 2854.
Figure 2 Adjusted 5-year risk for mortality and disease incidence by vigorous physical activity volume groups. Timescale was follow-up years. Adjusted for age, sex, wear time, light intensity, moderate intensity, frequency of vigorous bouts, smoking history, alcohol consumption, sleep score, diet, discretionary screen-time, education, self-reported parental history of CVD and cancer, and self-reported medication use (cholesterol, blood pressure, and diabetes). Mortality: n = 71 893; events: all-cause = 1,927, cardiovascular disease = 602, cancer = 1150. Cardiovascular disease: n = 71,049, events = 4567. Cancer: n = 71,070, events = 2854.CC BY-NC · PubMed Central
Figure 3 Adjusted survival curves for mortality and disease incidence by vigorous physical activity volume groups. Timescale was age. Adjusted for sex, wear time, light intensity, moderate intensity, frequency of vigorous bouts, smoking history, alcohol consumption, sleep score, diet, discretionary screen-time, education, self-reported parental history of CVD and cancer, and self-reported medication use (cholesterol, blood pressure, and diabetes). Mortality: n = 71 893; events: all-cause = 1,927, cardiovascular disease = 602, cancer = 1150. Cardiovascular disease: n = 71,049, events = 4567. Cancer: n = 71,070, events = 2854.
Figure 3 Adjusted survival curves for mortality and disease incidence by vigorous physical activity volume groups. Timescale was age. Adjusted for sex, wear time, light intensity, moderate intensity, frequency of vigorous bouts, smoking history, alcohol consumption, sleep score, diet, discretionary screen-time, education, self-reported parental history of CVD and cancer, and self-reported medication use (cholesterol, blood pressure, and diabetes). Mortality: n = 71 893; events: all-cause = 1,927, cardiovascular disease = 602, cancer = 1150. Cardiovascular disease: n = 71,049, events = 4567. Cancer: n = 71,070, events = 2854.CC BY-NC · PubMed Central
Figure 4 Dose–response association between vigorous physical activity volume (minutes/week) and all-cause, cardiovascular disease, and cancer mortality. Timescale was age. Adjusted for sex, wear time, light intensity, moderate intensity, frequency of vigorous bouts, smoking history, alcohol consumption, sleep score, diet, discretionary screen-time, education, self-reported parental history of CVD and cancer, and self-reported medication use (cholesterol, blood pressure, and diabetes). The range was capped at the 97.5 percentile to minimize the influence of sparse data. Sample = 71 893; events: all-cause = 1,927, cardiovascular disease = 602, cancer = 1150; reference= 2.2 min/week. Linearity: ACM (P < 0.01); CVD (P = 0.42); cancer (P < 0.01). Nadir: ACM [53.6 min/wk; HR = 0.64 (0.54, 0.77)]; cancer [55.4 min/wk; HR = 0.68 (0.52, 0.88)].
Figure 4 Dose–response association between vigorous physical activity volume (minutes/week) and all-cause, cardiovascular disease, and cancer mortality. Timescale was age. Adjusted for sex, wear time, light intensity, moderate intensity, frequency of vigorous bouts, smoking history, alcohol consumption, sleep score, diet, discretionary screen-time, education, self-reported parental history of CVD and cancer, and self-reported medication use (cholesterol, blood pressure, and diabetes). The range was capped at the 97.5 percentile to minimize the influence of sparse data. Sample = 71 893; events: all-cause = 1,927, cardiovascular disease = 602, cancer = 1150; reference= 2.2 min/week. Linearity: ACM (P < 0.01); CVD (P = 0.42); cancer (P < 0.01). Nadir: ACM [53.6 min/wk; HR = 0.64 (0.54, 0.77)]; cancer [55.4 min/wk; HR = 0.68 (0.52, 0.88)].CC BY-NC · PubMed Central
Figure 5 Dose–response association between vigorous physical activity volume (min/week) and incidence of cardiovascular disease (n = 71 049; events = 3730) and cancer (n = 71 070; events = 1315). Timescale was age. Adjusted for sex, wear time, light intensity physical activity, moderate intensity physical activity, frequency of vigorous bouts, smoking history, alcohol consumption, sleep score, diet, screentime, education, self-reported parental history of CVD and cancer, and self-reported medication use (cholesterol, blood pressure, and diabetes). The range was capped at the 97.5 percentile to minimize the influence of sparse data. Cardiovascular disease: n = 71,049, events = 4567. Cancer: n = 71,070, events = 2854. Reference = 2.17 min/week. Linearity: CVD (P < 0.01); cancer (P < 0.01). Nadir: CVD (56.5 min/wk; HR = 0.69 [0.63, 0.76]); cancer (46.3 min/wk; HR = 0.67 [0.55, 0.82]).
Figure 5 Dose–response association between vigorous physical activity volume (min/week) and incidence of cardiovascular disease (n = 71 049; events = 3730) and cancer (n = 71 070; events = 1315). Timescale was age. Adjusted for sex, wear time, light intensity physical activity, moderate intensity physical activity, frequency of vigorous bouts, smoking history, alcohol consumption, sleep score, diet, screentime, education, self-reported parental history of CVD and cancer, and self-reported medication use (cholesterol, blood pressure, and diabetes). The range was capped at the 97.5 percentile to minimize the influence of sparse data. Cardiovascular disease: n = 71,049, events = 4567. Cancer: n = 71,070, events = 2854. Reference = 2.17 min/week. Linearity: CVD (P < 0.01); cancer (P < 0.01). Nadir: CVD (56.5 min/wk; HR = 0.69 [0.63, 0.76]); cancer (46.3 min/wk; HR = 0.67 [0.55, 0.82]).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. Harrell, 2017, RMS: Regression Modeling Strategies. R package version 4.0-0

Cited by

See all 175

Metadata

Authors
Ahmadi, M. N., Clare, P. J., Katzmarzyk, P. T., del Pozo Cruz, B., Lee, I. M., & Stamatakis, E.
Affiliations
  • The University of Sydney (AU)
  • Pennington Biomedical Research Center (US)
  • Department of Sports Science and Clinical Biomechanics, University of Southern Denmark , Odense , Denmark
  • Brigham and Women's Hospital (US)
Corresponding author
Ahmadi, Matthew N
Venue
European Heart Journal
Published
2022-10-27
Volume
43
Issue
46
Pages
4801-4814
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W4307500053
Cited by
175
References
50
Citations by year
2026: 32 · 2025: 49 · 2024: 60 · 2023: 31 · 2022: 3
FWCI
22.14
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Civil War Book Review (submittedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by-nc)
Funders
Australian National Health and Medical Research Council (1194510)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
  • Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Keywords
high-intensity exercise, physical activity volume, physical activity frequency, dose-response relationship, optimal dose, all-cause mortality, cardiovascular mortality, cancer incidence, heart disease, cancer
MeSH terms
Female, Heart Diseases, Humans, Male, Neoplasms, Prospective Studies, Exercise

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vigorous physical activity, incident heart disease, and cancer: how little is enough? https://app.cochat.ai/papers/10.1093/eurheartj/ehac572
The paper
Ahmadi, M. N., Clare, P. J., Katzmarzyk, P. T., del Pozo Cruz, B., Lee, I. M., & Stamatakis, E. (2022). Vigorous physical activity, incident heart disease, and cancer: how little is enough? European Heart Journal. https://doi.org/10.1093/eurheartj/ehac572

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.